Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Nu Skin Enterprises(BTCA)PetIQTrxade GroupTrxade Group
SymbolNYSE:NUSOTCMKTS:BTCANASDAQ:PETQOTCMKTS:TRXDNASDAQ:MEDS
Price Information
Current Price$53.01$120,000.00$36.50$4.92$4.85
52 Week RangeHoldN/ABuyN/ABuy
MarketRank™
Overall Score2.10.21.60.81.8
Analysis Score1.10.03.50.03.4
Community Score2.60.02.52.32.2
Dividend Score2.50.00.00.00.0
Ownership Score1.70.80.01.71.7
Earnings & Valuation Score2.50.01.90.01.9
Analyst Ratings
Consensus RecommendationHoldN/ABuyN/ABuy
Consensus Price Target$55.83N/A$78.75N/A$12.33
% Upside from Price Target5.33% upsideN/A115.75% upsideN/A154.30% upside
Trade Information
Market Cap$2.66 billion$1.20 billion$1.08 billion$193.04 million$39.82 million
Beta1.370.011.51.351.42
Average Volume566,771N/A289,7154,24796,701
Sales & Book Value
Annual Revenue$2.42 billionN/A$709.43 million$3.83 million$7.44 million
Price / Sales1.11N/A1.4950.405.28
Cashflow$4.34 per shareN/A$1.40 per share$0.00 per share$0.04 per share
Price / Cash12.22N/A25.985,362.12124.82
Book Value$15.74 per shareN/A$11.60 per share$0.03 per share$0.63 per share
Price / Book3.37N/A3.15164.007.70
Profitability
Net Income$173.55 millionN/A$-11,450,000.00$10,000.00$-280,000.00
EPS$3.10N/A$1.07N/A$0.03
Trailing P/E Ratio17.850.00N/AN/A161.67
Forward P/E Ratio14.2535.1021.09
P/E Growth2.03N/A1.44N/A0.83
Net Margins6.54%N/A-10.13%0.33%-4.28%
Return on Equity (ROE)19.18%N/A4.47%1.26%-8.28%
Return on Assets (ROA)8.87%N/A1.91%0.61%-7.09%
Dividend
Annual Payout$1.52N/AN/AN/AN/A
Dividend Yield2.87%N/AN/AN/AN/A
Three-Year Dividend Growth4.17%N/AN/AN/AN/A
Payout Ratio49.03%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.38%N/A1.19%0.26%0.02%
Current Ratio1.66%N/A2.45%4.51%19.89%
Quick Ratio1.08%N/A1.62%4.45%16.81%
Ownership Information
Institutional Ownership Percentage73.75%N/AN/AN/A13.13%
Insider Ownership Percentage3.40%41.40%24.12%71.30%71.30%
Miscellaneous
Employees5,000N/A1,0153129
Shares Outstanding50.84 million10,00028.94 million39.24 million8.09 million
Next Earnings Date5/5/2021 (Confirmed)N/A5/6/2021 (Estimated)N/A5/3/2021 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable
SourceHeadline
Short Interest in Trxade Group, Inc. (NASDAQ:MEDS) Increases By 561.8%Short Interest in Trxade Group, Inc. (NASDAQ:MEDS) Increases By 561.8%
americanbankingnews.com - April 13 at 5:38 AM
Trxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern TimeTrxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern Time
finance.yahoo.com - April 12 at 7:08 PM
TRxADE Group to Present at Planet MicroCap ShowcaseTRxADE Group to Present at Planet MicroCap Showcase
finance.yahoo.com - April 9 at 8:50 AM
Trxade Group, Inc. (NASDAQ:MEDS) to Post Q1 2021 Earnings of ($0.03) Per Share, Taglich Brothers ForecastsTrxade Group, Inc. (NASDAQ:MEDS) to Post Q1 2021 Earnings of ($0.03) Per Share, Taglich Brothers Forecasts
americanbankingnews.com - April 8 at 7:04 AM
Trxade Group, Inc. (NASDAQ:MEDS) Forecasted to Post Q1 2022 Earnings of $0.02 Per ShareTrxade Group, Inc. (NASDAQ:MEDS) Forecasted to Post Q1 2022 Earnings of $0.02 Per Share
americanbankingnews.com - April 7 at 6:44 AM
FY2020 Earnings Forecast for Trxade Group, Inc. (NASDAQ:MEDS) Issued By Colliers SecuritiesFY2020 Earnings Forecast for Trxade Group, Inc. (NASDAQ:MEDS) Issued By Colliers Securities
americanbankingnews.com - April 1 at 6:34 AM
Trxade Group, Inc.s (MEDS) CEO Suren Ajjarapu on Q4 2020 Results - Earnings Call TranscriptTrxade Group, Inc.'s (MEDS) CEO Suren Ajjarapu on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 31 at 7:05 PM
Colliers Securities Weighs in on Trxade Group, Inc.s FY2021 Earnings (NASDAQ:MEDS)Colliers Securities Weighs in on Trxade Group, Inc.'s FY2021 Earnings (NASDAQ:MEDS)
americanbankingnews.com - March 31 at 8:34 AM
Trxade Group, Inc. (NASDAQ:MEDS) Given Average Recommendation of "Buy" by BrokeragesTrxade Group, Inc. (NASDAQ:MEDS) Given Average Recommendation of "Buy" by Brokerages
americanbankingnews.com - March 30 at 12:47 PM
Colliers Securities Reaffirms Buy Rating for Trxade Group (NASDAQ:MEDS)Colliers Securities Reaffirms Buy Rating for Trxade Group (NASDAQ:MEDS)
americanbankingnews.com - March 30 at 9:06 AM
Trxade Group (NASDAQ:MEDS) Releases  Earnings Results, Misses Estimates By $0.21 EPSTrxade Group (NASDAQ:MEDS) Releases Earnings Results, Misses Estimates By $0.21 EPS
americanbankingnews.com - March 30 at 7:46 AM
Trxade Group, Inc. to Host Earnings CallTrxade Group, Inc. to Host Earnings Call
finance.yahoo.com - March 29 at 3:38 PM
Trxade Group to Report Fourth Quarter and Full Year 2020 Results on Monday, March 29th at 5:00 p.m. Eastern TimeTrxade Group to Report Fourth Quarter and Full Year 2020 Results on Monday, March 29th at 5:00 p.m. Eastern Time
finance.yahoo.com - March 15 at 5:49 PM
The Trxade Group (NASDAQ:MEDS) Share Price Is Up 143% And Shareholders Are Boasting About ItThe Trxade Group (NASDAQ:MEDS) Share Price Is Up 143% And Shareholders Are Boasting About It
finance.yahoo.com - February 5 at 2:27 PM
Trxade Group to Postpone Virtual Roadshow PresentationTrxade Group to Postpone Virtual Roadshow Presentation
finance.yahoo.com - February 1 at 7:30 PM
Trxade Group to Host Virtual Roadshow on Wednesday, February 3, 2021 at 11:00 a.m. Eastern TimeTrxade Group to Host Virtual Roadshow on Wednesday, February 3, 2021 at 11:00 a.m. Eastern Time
finance.yahoo.com - January 20 at 8:50 AM
Trxade Group, Inc.: Trxade Group Announces Strategic Telehealth Partnership with KPH Healthcare ServicesTrxade Group, Inc.: Trxade Group Announces Strategic Telehealth Partnership with KPH Healthcare Services
finanznachrichten.de - December 11 at 10:33 PM
Trxade Group Announces Strategic Telehealth Partnership with KPH Healthcare ServicesTrxade Group Announces Strategic Telehealth Partnership with KPH Healthcare Services
finance.yahoo.com - December 10 at 11:27 AM
Trxade Group, Inc.: Trxade Group Launches Trxade Prime Purchasing Solution to Simplify Prescription DistributionTrxade Group, Inc.: Trxade Group Launches Trxade Prime Purchasing Solution to Simplify Prescription Distribution
finanznachrichten.de - December 9 at 8:25 PM
Trxade Group Launches Trxade Prime Purchasing Solution to Simplify Prescription DistributionTrxade Group Launches Trxade Prime Purchasing Solution to Simplify Prescription Distribution
finance.yahoo.com - December 8 at 9:18 AM
Trxade Group Inc. (MEDS)Trxade Group Inc. (MEDS)
realmoney.thestreet.com - December 4 at 10:03 PM
Benzingas Top Upgrades, Downgrades For December 3, 2020Benzinga's Top Upgrades, Downgrades For December 3, 2020
finance.yahoo.com - December 3 at 3:21 PM
TRxADE Group to Present at the Diamond Equity Research Emerging Growth InvitationalTRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational
finance.yahoo.com - November 18 at 8:44 AM
Why Trxade Groups Stock Is Trading Higher TodayWhy Trxade Group's Stock Is Trading Higher Today
benzinga.com - November 10 at 6:30 PM
Trxade Groups Big New Deal With AmazonTrxade Group's Big New Deal With Amazon
msn.com - November 10 at 1:29 PM
DateCompanyBrokerageAction
2/12/2021Nu Skin EnterprisesDA DavidsonDowngrade
2/2/2021Nu Skin EnterprisesJefferies Financial GroupBoost Price Target
11/5/2020Nu Skin EnterprisesDeutsche Bank AktiengesellschaftBoost Price Target
10/2/2020Nu Skin EnterprisesBank of AmericaUpgrade
8/6/2020Nu Skin EnterprisesStifel NicolausBoost Price Target
7/7/2020Nu Skin EnterprisesCitigroupReiterated Rating
5/29/2020Nu Skin EnterprisesTigress FinancialReiterated Rating
3/4/2021PetIQRaymond JamesBoost Price Target
11/9/2020PetIQOppenheimerReiterated Rating
8/17/2020PetIQGuggenheimBoost Price Target
7/20/2020PetIQSunTrust BanksBoost Price Target
9/28/2018PetIQCL KingInitiated Coverage
3/30/2021Trxade GroupColliers SecuritiesReiterated Rating
2/26/2021Trxade GroupMaxim GroupInitiated Coverage
12/3/2020Trxade GroupNational SecuritiesInitiated Coverage
6/10/2020Trxade GroupTaglich BrothersReiterated Rating
4/30/2020Trxade GroupDougherty & CoReiterated Rating
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.